Research Groups

Early Detection and Prevention - Prevention and Implementation Group

Previous Publications - All Publications 2017-2013

1. Huang J., Zagai U., Hallmans G., Nyren O., Engstrand L., Stolzenberg-Solomon R., Duell E. J., Overvad K., Katzke V. A., Kaaks R., Jenab M., Park J. Y., Murillo R., Trichopoulou A., Lagiou P., Bamia C., Bradbury K. E., Riboli E., Aune D., Tsilidis K. K., Capella G., Agudo A., Krogh V., Palli D., Panico S., Weiderpass E., Tjonneland A., Olsen A., Martinez B., Redondo-Sanchez D., Chirlaque M. D., Hm Peeters P., Regner S., Lindkvist B., Naccarati A., Ardanaz E., Larranaga N., Boutron-Ruault M. C., Rebours V., Barre A., Bueno-de-Mesquita H. B., Ye W. (2017) Helicobacter pylori infection, chronic corpus atrophic gastritis and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: A nested case-control study Int J Cancer; 140(8):1727-1735. PMID: 28032715

2. Rodriguez A. C., Avila C., Herrero R., Hildesheim A., Sherman M. E., Burk R. D., Morales J., Alfaro M., Guillen D., Trejos M. E., Vargas R. M., Torres G., Schiffman M. (2017) Cervical cancer incidence after screening with HPV, cytology, and visual methods: 18-Year follow-up of the Guanacaste cohort Int J Cancer; 140(8):1926-1934. PMID: 28120391

3. Denny L., de Sanjose S., Mutebi M., Anderson B. O., Kim J., Jeronimo J., Herrero R., Yeates K., Ginsburg O., Sankaranarayanan R. (2017) Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries Lancet; 389(10071):861-870. PMID: 27814963

4. Ginindza T. G., Dlamini X., Almonte M., Herrero R., Jolly P. E., Tsoka-Gwegweni J. M., Weiderpass E., Broutet N., Sartorius B. (2017) Prevalence of and Associated Risk Factors for High Risk Human Papillomavirus among Sexually Active Women, Swaziland PLoS ONE; 12(1):e0170189. PMID: 28114325

5. Muwonge R., Ngo Mbus L., Ngoma T., Gombe Mbalawa C., Dolo A., da Ganda Manuel M., Nouhou H., Nacoulma M., Mwaiselage J., Koulibaly M., Bayo S., Nsonde Malanda J., De Vuyst H., Herrero R., Sankaranarayanan R., Keita N. (2016) Socio-demographic and reproductive determinants of cervical neoplasia in seven sub-Sahara African countries Cancer Causes Control; 27(12):1437-1446. PMID: 27822586

6. Lesseur C., Diergaarde B., Olshan A. F., Wunsch-Filho V., Ness A. R., Liu G., Lacko M., Eluf-Neto J., Franceschi S., Lagiou P., Macfarlane G. J., Richiardi L., Boccia S., Polesel J., Kjaerheim K., Zaridze D., Johansson M., Menezes A. M., Curado M. P., Robinson M., Ahrens W., Canova C., Znaor A., Castellsague X., Conway D. I., Holcatova I., Mates D., Vilensky M., Healy C. M., Szeszenia-Dabrowska N., Fabianova E., Lissowska J., Grandis J. R., Weissler M. C., Tajara E. H., Nunes F. D., de Carvalho M. B., Thomas S., Hung R. J., Peters W. H., Herrero R., Cadoni G., Bueno-de-Mesquita H. B., Steffen A., Agudo A., Shangina O., Xiao X., Gaborieau V., Chabrier A., Anantharaman D., Boffetta P., Amos C. I., McKay J. D., Brennan P. (2016) Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer Nat Genet; 48(12):1544-1550. PMID: 27749845

7. Costas L., Benavente Y., Olmedo-Requena R., Casabonne D., Robles C., Gonzalez-Barca E. M., de la Banda E., Alonso E., Aymerich M., Tardon A., Marcos-Gragera R., Gimeno-Vazquez E., Gomez-Acebo I., Papantoniou K., Castano-Vinyals G., Aragones N., Pollan M., Kogevinas M., de Sanjose S. (2016) Night shift work and chronic lymphocytic leukemia in the MCC-Spain case-control study Int J Cancer; 139(9):1994-2000. PMID: 27416551

8. Clifford G. M., de Vuyst H., Tenet V., Plummer M., Tully S., Franceschi S. (2016) Effect of HIV Infection on Human Papillomavirus Types Causing Invasive Cervical Cancer in Africa J Acquir Immune Defic Syndr; 73(3):332-339. PMID: 27331659

9. Huseinovic E., Winkvist A., Slimani N., Park M. K., Freisling H., Boeing H., Buckland G., Schwingshackl L., Weiderpass E., Rostgaard-Hansen A. L., Tjonneland A., Affret A., Boutron-Ruault M. C., Fagherazzi G., Katzke V., Kuhn T., Naska A., Orfanos P., Trichopoulou A., Pala V., Palli D., Ricceri F., Santucci de Magistris M., Tumino R., Engeset D., Enget T., Skeie G., Barricarte A., Bonet C. B., Chirlaque M. D., Amiano P., Quiros J. R., Sanchez M. J., Dias J. A., Drake I., Wennberg M., Boer J., Ocke M. C., Verschuren W., Lassale C., Perez-Cornago A., Riboli E., Ward H., Forslund H. B. (2016) Meal patterns across ten European countries - results from the European Prospective Investigation into Cancer and Nutrition (EPIC) calibration study Public Health Nutr; 19(15):2769-80. PMID: 27194183

10. Murillo R., Herrero R., Sierra M. S., Forman D. (2016) Cervical cancer in Central and South America: Burden of disease and status of disease control Cancer Epidemiol; S121-s130. PMID: 27678314

11. Combita A. L., Gheit T., Gonzalez P., Puerto D., Murillo R. H., Montoya L., Vorsters A., Van Keer S., Van Damme P., Tommasino M., Hernandez-Suarez G., Sanchez L., Herrero R., Wiesner C. (2016) Comparison between Urine and Cervical Samples for HPV DNA Detection and Typing in Young Women in Colombia Cancer Prev Res (Phila); 9(9):766-71. PMID: 27417431

12. Talarico S., Safaeian M., Gonzalez P., Hildesheim A., Herrero R., Porras C., Cortes B., Larson A., Fang F. C., Salama N. R. (2016) Quantitative Detection and Genotyping of Helicobacter pylori from Stool using Droplet Digital PCR Reveals Variation in Bacterial Loads that Correlates with cagA Virulence Gene Carriage Helicobacter; 21(4):325-33. PMID: 26667241

13. Negulescu R. A., Catarino R., De Vuyst H., Undurraga-Malinverno M., Meyer-Hamme U., Alec M., Campana A., Vassilakos P., Petignat P. (2016) Web-based instrument to assess skills in visual inspection of the cervix among healthcare providers Int J Gynaecol Obstet; 134(1):107-13. PMID: 27126908

14. Bruni L., Diaz M., Barrionuevo-Rosas L., Herrero R., Bray F., Bosch F. X., de Sanjose S., Castellsague X. (2016) Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis Lancet Glob Health; 4(7):e453-63. PMID: 27340003

15. Berthiller J., Straif K., Agudo A., Ahrens W., Bezerra Dos Santos A., Boccia S., Cadoni G., Canova C., Castellsague X., Chen C., Conway D., Curado M. P., Dal Maso L., Daudt A. W., Fabianova E., Fernandez L., Franceschi S., Fukuyama E. E., Hayes R. B., Healy C., Herrero R., Holcatova I., Kelsey K., Kjaerheim K., Koifman S., Lagiou P., La Vecchia C., Lazarus P., Levi F., Lissowska J., Macfarlane T., Mates D., McClean M., Menezes A., Merletti F., Morgenstern H., Muscat J., Olshan A. F., Purdue M., Ramroth H., Rudnai P., Schwartz S. M., Serraino D., Shangina O., Smith E., Sturgis E. M., Szeszenia-Dabrowska N., Thomson P., Vaughan T. L., Vilensky M., Wei Q., Winn D. M., Wunsch-Filho V., Zhang Z. F., Znaor A., Ferro G., Brennan P., Boffetta P., Hashibe M., Lee Y. C. (2016) Low frequency of cigarette smoking and the risk of head and neck cancer in the INHANCE consortium pooled analysis Int J Epidemiol; 45(3):835-45. PMID: 26228584

16. Santesso N., Mustafa R. A., Schunemann H. J., Arbyn M., Blumenthal P. D., Cain J., Chirenje M., Denny L., De Vuyst H., Eckert L. O., Forhan S. E., Franco E. L., Gage J. C., Garcia F., Herrero R., Jeronimo J., Lu E. R., Luciani S., Quek S. C., Sankaranarayanan R., Tsu V., Broutet N. (2016) World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer Int J Gynaecol Obstet; 132(3):252-8. PMID: 26868062

17. Harari A., Chen Z., Rodriguez A. C., Hildesheim A., Porras C., Herrero R., Wacholder S., Panagiotou O. A., Befano B., Burk R. D., Schiffman M. (2016) Cross-protection of the Bivalent Human Papillomavirus (HPV) Vaccine Against Variants of Genetically Related High-Risk HPV Infections J Infect Dis; 213(6):939-47. PMID: 26518044

18. Murillo R., Diaz S., Perry F., Poveda C., Pineros M., Sanchez O., Buitrago L., Gamboa O., Lozano T., Yu H., Wang C. Y., Duggan C., Thomas D. B., Anderson B. O. (2016) Increased breast cancer screening and downstaging in Colombian women: A randomized trial of opportunistic breast-screening Int J Cancer; 138(3):705-13. PMID: 26264446

19. Hernandez-Avila M., Torres-Ibarra L., Stanley M., Salmeron J., Cruz-Valdez A., Munoz N., Herrero R., Villasenor-Ruiz I. F., Lazcano-Ponce E. (2016) Evaluation of the immunogenicity of the quadrivalent HPV vaccine using 2 versus 3 doses at month 21: An epidemiological surveillance mechanism for alternate vaccination schemes Hum Vaccin Immunother; 12(1):30-8. PMID: 26211489

20. Beachler D. C., Kreimer A. R., Schiffman M., Herrero R., Wacholder S., Rodriguez A. C., Lowy D. R., Porras C., Schiller J. T., Quint W., Jimenez S., Safaeian M., Struijk L., Schussler J., Hildesheim A., Gonzalez P. (2016) Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection J Natl Cancer Inst; 108(1):. PMID: 26467666

21. Armaroli P., Villain P., Suonio E., Almonte M., Anttila A., Atkin W. S., Dean P. B., de Koning H. J., Dillner L., Herrero R., Kuipers E. J., Lansdorp-Vogelaar I., Minozzi S., Paci E., Regula J., Tornberg S., Segnan N. (2015) European Code against Cancer, 4th Edition: Cancer screening Cancer Epidemiol; S139-52. PMID: 26596722

22. Minozzi S., Armaroli P., Espina C., Villain P., Wiseman M., Schuz J., Segnan N. (2015) European Code against Cancer 4th Edition: Process of reviewing the scientific evidence and revising the recommendations Cancer Epidemiol; S11-9. PMID: 26439654

23. Schuz J., Espina C., Villain P., Herrero R., Leon M. E., Minozzi S., Romieu I., Segnan N., Wardle J., Wiseman M., Belardelli F., Bettcher D., Cavalli F., Galea G., Lenoir G., Martin-Moreno J. M., Nicula F. A., Olsen J. H., Patnick J., Primic-Zakelj M., Puska P., van Leeuwen F. E., Wiestler O., Zatonski W. (2015) European Code against Cancer 4th Edition: 12 ways to reduce your cancer risk Cancer Epidemiol; S1-10. PMID: 26164654

24. Villain P., Gonzalez P., Almonte M., Franceschi S., Dillner J., Anttila A., Park J. Y., De Vuyst H., Herrero R. (2015) European Code against Cancer 4th Edition: Infections and Cancer Cancer Epidemiol; S120-38. PMID: 26589774

25. Shimakawa Y., Lemoine M., Bottomley C., Njai H. F., Ndow G., Jatta A., Tamba S., Bojang L., Taal M., Nyan O., D'Alessandro U., Njie R., Thursz M., Hall A. J. (2015) Birth order and risk of hepatocellular carcinoma in chronic carriers of hepatitis B virus: a case-control study in The Gambia Liver Int; 35(10):2318-26. PMID: 25728498

26. Bryant D., Hibbitts S., Almonte M., Tristram A., Fiander A., Powell N. (2015) Human papillomavirus type 16 L1/L2 DNA methylation shows weak association with cervical disease grade in young women Journal of Clinical Virology; 66-71. PMID: 25866341

27. Antilla A., Arbyn M, De Vuyst H., Dillner J., Dillner L., Franceschi S., Patnick J., Ronco G., Segnan N., Suonio E., Tornberg S., von Karsa L. (2015) European guidelines for quality assurance in cervical cancer screening ; .

28. Panagiotou O.A., Befano B.L., Gonzalez P., Rodriguez A.C., Herrero R., Schiller J.T., Kreimer A.R., Schiffman M., Hildesheim A., Wilcox A.J., Wacholder S. (2015) Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial BMJ; h4358.

29. Park M.K., Park J.Y., Nicolas G., Paik H.Y., Kim J., Slimani N. (2015) Adapting a standardised international 24 h dietary recall methodology (GloboDiet software) for research and dietary surveillance in Korea Br. J Nutr; 113(11):1810-1818. PMID: 25899045

30. Conway D.I., Brenner D.R., McMahon A.D., Macpherson L.M., Agudo A., Ahrens W., Bosetti C., Brenner H., Castellsague X., Chen C., Curado M.P., Curioni O.A., Dal Maso L., Daudt A.W., de Gois Filho J.F., D'Souza G., Edefonti V., Fabianova E., Fernandez L., Franceschi S., Gillison M., Hayes R.B., Healy C.M., Herrero R., Holcatova I., Jayaprakash V., Kelsey K., Kjaerheim K., Koifman S., La Vecchia C., Lagiou P., Lazarus P., Levi F., Lissowska J., Luce D., Macfarlane T.V., Mates D., Matos E., McClean M., Menezes A.M., Menvielle G., Merletti F., Morgenstern H., Moysich K., Muller H., Muscat J., Olshan A.F., Purdue M.P., Ramroth H., Richiardi L., Rudnai P., Schantz S., Schwartz S.M., Shangina O., Simonato L., Smith E., Stucker I., Sturgis E.M., Szeszenia-Dabrowska N., Talamini R., Thomson P., Vaughan T.L., Wei Q., Winn D.M., Wunsch-Filho V., Yu G.P., Zhang Z.F., Zheng T., Znaor A., Boffetta P., Chuang S.C., Ghodrat M., Amy Lee Y.C., Hashibe M., Brennan P. (2015) Estimating and explaining the effect of education and income on head and neck cancer risk: INHANCE consortium pooled analysis of 31 case-control studies from 27 countries Int J Cancer; 136(5):1125-1139. PMID: 24996155

31. Arrossi S., Thouyaret L., Laudi R., Marin O., Ramirez J., Paolino M., Herrero R., Campanera A. (2015) Implementation of HPV-testing for cervical cancer screening in programmatic contexts: The Jujuy demonstration project in Argentina Int. J Cancer; 137(7):1709-1718. PMID: 25807897

32. Toporcov T.N., Znaor A., Zhang Z.F., Yu G.P., Winn D.M., Wei Q., Vilensky M., Vaughan T., Thomson P., Talamini R., Szeszenia-Dabrowska N., Sturgis E.M., Smith E., Shangina O., Schwartz S.M., Schantz S., Rudnai P., Richiardi L., Ramroth H., Purdue M.P., Olshan A.F., Eluf-Neto J., Muscat J., Moyses R.A., Morgenstern H., Menezes A., McClean M., Matsuo K., Mates D., Macfarlane T.V., Lissowska J., Levi F., Lazarus P., La Vecchia C., Lagiou P., Koifman S., Kjaerheim K., Kelsey K., Holcatova I., Herrero R., Healy C., Hayes R.B., Franceschi S., Fernandez L., Fabianova E., Daudt A.W., Curioni O.A., Maso L.D., Curado M.P., Conway D.I., Chen C., Castellsague X., Canova C., Cadoni G., Brennan P., Boccia S., Antunes J.L., Ahrens W., Agudo A., Boffetta P., Hashibe M., Lee Y.C., Filho V.W. (2015) Risk factors for head and neck cancer in young adults: a pooled analysis in the INHANCE consortium Int. J Epidemiol; 44(1):169-185.

33. Quesada P., Whitby D., Benavente Y., Miley W., Labo N., Chichareon S., Trong N., Shin H.R., Anh P.T., Thomas J., Matos E., Herrero R., Munoz N., Molano M., Franceschi S., de Sanjose S. (2015) Hepatitis C virus seroprevalence in the general female population from 8 countries J Clin. Virol; 89-93.

34. de Batlle J., Ferrari P., Chajes V., Park J.Y., Slimani N., McKenzie F., Overvad K., Roswall N., Tjonneland A., Boutron-Ruault M.C., Clavel-Chapelon F., Fagherazzi G., Katzke V., Kaaks R., Bergmann M.M., Trichopoulou A., Lagiou P., Trichopoulos D., Palli D., Sieri S., Panico S., Tumino R., Vineis P., Bueno-de-Mesquita H.B., Peeters P.H., Hjartaker A., Engeset D., Weiderpass E., Sanchez S., Travier N., Sanchez M.J., Amiano P., Chirlaque M.D., Barricarte Gurrea A., Khaw K.T., Key T.J., Bradbury K.E., Ericson U., Sonestedt E., Van Guelpen B., Schneede J., Riboli E., Romieu I. (2015) Dietary folate intake and breast cancer risk: European prospective investigation into cancer and nutrition J Natl Cancer Inst; 107(1):367. PMID: 25505228

35. Porras C., Hildesheim A., Gonzalez P., Schiffman M., Rodriguez A.C., Wacholder S., Jimenez S., Quint W., Guillen D., Kreimer A.R., Herrero R. (2015) Performance of self-collected cervical samples in screening for future precancer using human papillomavirus DNA testing J Natl Cancer Inst; 107(1):400. PMID: 25479804

36. Arrossi S., Thouyaret L., Herrero R., Campanera A., Magdaleno A., Cuberli M., Barletta P., Laudi R., Orellana L. (2015) Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trial Lancet Glob. Health; 3(2):e85-e94. PMID: 25617202

37. Herrero R., Gonzalez P., Markowitz L.E. (2015) Present status of human papillomavirus vaccine development and implementation Lancet Oncol; 16(5):e206-e216. PMID: 25943065

38. Kreimer A.R., Struyf F., Del Rosario-Raymundo M.R., Hildesheim A., Skinner S.R., Wacholder S., Garland S.M., Herrero R., David M.P., Wheeler C.M. (2015) Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials Lancet Oncol; 16(7):775-786. PMID: 26071347

39. Lowy D.R., Herrero R., Hildesheim A., Participants in the IARC/NCI workshop on Primary Endpoints for Prophylactic HPV Vaccine Trials (2015) Primary endpoints for future prophylactic human papillomavirus vaccine trials: towards infection and immunobridging Lancet Oncol; 16(5):e226-e233. PMID: 25943067

40. (2015) European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination Papillomavirus Research; 22-31.

41. Almonte M., Ferreccio C., Luciani S., Gonzales M., Delgado J.M., Santos C., Alvarez M., Cuzick J., Sasieni P. (2015) Visual Inspection after Acetic Acid (VIA) Is Highly Heterogeneous in Primary Cervical Screening in Amazonian Peru PLoS. One; 10(1):e0115355. PMID: 25635965

42. Gonzalez P., Hildesheim A., Herrero R., Katki H., Wacholder S., Porras C., Safaeian M., Jimenez S., Darragh T.M., Cortes B., Befano B., Schiffman M., Carvajal L., Palefsky J., Schiller J., Ocampo R., Schussler J., Lowy D., Guillen D., Stoler M.H., Quint W., Morales J., Avila C., Rodriguez A.C., Kreimer A.R. (2015) Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa Rica Vaccine; 33(18):2141-2151. PMID: 25796338

43. Campos N.G., Burger E.A., Sy S., Sharma M., Schiffman M., Rodriguez A.C., Hildesheim A., Herrero R., Kim J.J. (2014) An updated natural history model of cervical cancer: derivation of model parameters Am J Epidemiol; 180(5):545-555.

44. Lang Kuhs K.A., Porras C., Schiller J.T., Rodriguez A.C., Schiffman M., Gonzalez P., Wacholder S., Ghosh A., Li Y., Lowy D.R., Kreimer A.R., Poncelet S., Schussler J., Quint W., Van Doorn L.J., Sherman M.E., Sidawy M., Herrero R., Hildesheim A., Safaeian M. (2014) Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates Am. J. Epidemiol; 180(6):599-607.

45. Herrero R., Park J.Y., Forman D. (2014) The fight against gastric cancer - the IARC Working Group report Best. Pract. Res Clin Gastroenterol; 28(6):1107-1114.

46. Robbins H.A., Li Y., Porras C., Pawlita M., Ghosh A., Rodriguez A.C., Schiffman M., Wacholder S., Kemp T.J., Gonzalez P., Schiller J., Lowy D., Esser M., Matys K., Quint W., Van Doorn L.J., Herrero R., Pinto L.A., Hildesheim A., Waterboer T., Safaeian M. (2014) Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus BMC. Infect Dis; 120.

47. Park J.Y., von Karsa L., Herrero R. (2014) Prevention strategies for gastric cancer: a global perspective Clin Endosc; 47(6):478-489.

48. Leoncini E., Ricciardi W., Cadoni G., Arzani D., Petrelli L., Paludetti G., Brennan P., Luce D., Stucker I., Matsuo K., Talamini R., La Vecchia C., Olshan A.F., Winn D.M., Herrero R., Franceschi S., Castellsague X., Muscat J., Morgenstern H., Zhang Z.F., Levi F., Dal Maso L., Kelsey K., McClean M., Vaughan T.L., Lazarus P., Purdue M.P., Hayes R.B., Chen C., Schwartz S.M., Shangina O., Koifman S., Ahrens W., Matos E., Lagiou P., Lissowska J., Szeszenia-Dabrowska N., Fernandez L., Menezes A., Agudo A., Daudt A.W., Richiardi L., Kjaerheim K., Mates D., Betka J., Yu G.P., Schantz S., Simonato L., Brenner H., Conway D.I., Macfarlane T.V., Thomson P., Fabianova E., Znaor A., Rudnai P., Healy C., Boffetta P., Chuang S.C., Lee Y.C., Hashibe M., Boccia S. (2014) Adult height and head and neck cancer: a pooled analysis within the INHANCE Consortium Eur J Epidemiol; 29(1):35-48.

49. Robbins H.A., Kemp T.J., Porras C., Rodriguez A.C., Schiffman M., Wacholder S., Gonzalez P., Schiller J., Lowy D., Poncelet S., Esser M., Matys K., Hildesheim A., Pinto L.A., Herrero R., Safaeian M. (2014) Comparison of antibody responses to human papillomavirus vaccination as measured by three assays Front Oncol; 328.

50. Bedoya A.M., Tate D.J., Baena A., Cordoba C.M., Borrero M., Pareja R., Rojas F., Patterson J.R., Herrero R., Zea A.H., Sanchez G.I. (2014) Immunosuppression in cervical cancer with special reference to arginase activity Gynecol. Oncol; 135(1):74-80.

51. Robbins H.A., Waterboer T., Porras C., Kemp T.J., Pawlita M., Rodriguez A.C., Wacholder S., Gonzalez P., Schiller J.T., Lowy D.R., Esser M., Matys K., Poncelet S., Herrero R., Hildesheim A., Pinto L.A., Safaeian M. (2014) Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay Hum. Vaccin. Immunother; 10(10):2965-2974.

52. Combes J.D., Pawlita M., Waterboer T., Hammouda D., Rajkumar T., Vanhems P., Snijders P., Herrero R., Franceschi S., Clifford G. (2014) Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer Int J Cancer; 135(10):2453-2461.

53. Lang Kuhs K.A., Gonzalez P., Rodriguez A.C., Van Doorn L.J., Schiffman M., Struijk L., Chen S., Quint W., Lowy D.R., Porras C., DelVecchio C., Jimenez S., Safaeian M., Schiller J.T., Wacholder S., Herrero R., Hildesheim A., Kreimer A.R. (2014) Reduced Prevalence of Vulvar HPV16/18 Infection Among Women Who Received the HPV16/18 Bivalent Vaccine: A Nested Analysis Within the Costa Rica Vaccine Trial J Infect Dis; 210(12):1890-1899.

54. Herrero R., Parsonnet J., Greenberg E.R. (2014) Prevention of gastric cancer JAMA; 312(12):1197-1198.

55. Ronco G., Dillner J., Elfstrom K.M., Tunesi S., Snijders P.J., Arbyn M., Kitchener H., Segnan N., Gilham C., Giorgi-Rossi P., Berkhof J., Peto J., Meijer C.J. (2014) Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials Lancet; 383(9916):524-532.

56. Anantharaman D., Chabrier A., Gaborieau V., Franceschi S., Herrero R., Rajkumar T., Samant T., Mahimkar M.B., Brennan P., McKay J.D. (2014) Genetic variants in nicotine addiction and alcohol metabolism genes, oral cancer risk and the propensity to smoke and drink alcohol: a replication study in India PLoS ONE; 9(2):e88240.

57. De Vuyst H., Mugo N.R., Franceschi S., McKenzie K., Tenet V., Njoroge J., Rana F.S., Sakr S.R., Snijders P.J., Chung M.H. (2014) Residual Disease and HPV Persistence after Cryotherapy for Cervical Intraepithelial Neoplasia Grade 2/3 in HIV-Positive Women in Kenya PLoS ONE; 9(10):e111037.

58. Guevara E., Baena A., Almonte M., Salaza J.E., Gaviria A., Sanchez G.I. (2014) Revista Facultad Nacional de Salud Publica; 32(2):54-60.

59. Lazcano-Ponce E., Stanley M., Munoz N., Torres L., Cruz-Valdez A., Salmeron J., Rojas R., Herrero R., Hernandez-Avila M. (2014) Overcoming barriers to HPV vaccination: Non-inferiority of antibody response to human papillomavirus 16/18 vaccine in adolescents vaccinated with a two-dose vs. a three-dose schedule at 21 months Vaccine; 32(6):725-732.

60. Chen A.A., Heideman D.A., Boon D., Chen Z., Burk R.D., De Vuyst H., Gheit T., Snijders P.J., Tommasino M., Franceschi S., Clifford G.M. (2014) Human papillomavirus 33 worldwide genetic variation and associated risk of cervical cancer Virology; 356-362.

61. Rollan A., Arab J.P., Camargo M.C., Candia R., Harris P., Ferreccio C., Rabkin C.S., Gana J.C., Cortes P., Herrero R., Duran L., Garcia A., Toledo C., Espino A., Lustig N., Sarfatis A., Figueroa C., Torres J., Riquelme A. (2014) Management of Helicobacter pylori infection in Latin America: A Delphi technique-based consensus World J Gastroenterol; 20(31):10969-10983.

62. Rodriguez A.C., Solomon D., Herrero R., Hildesheim A., Gonzalez P., Wacholder S., Porras C., Jimenez S., Schiffman M. (2013) Impact of human papillomavirus vaccination on cervical cytology screening, colposcopy, and treatment Am. J Epidemiol; 178(5):752-760.

63. Porras C., Nodora J., Sexton R., Ferreccio C., Jimenez S., Dominguez R.L., Cook P., Anderson G., Morgan D.R., Baker L.H., Greenberg E.R., Herrero R. (2013) Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701) Cancer Causes Control; 24(2):209-215.

64. Torres J., Correa P., Ferreccio C., Hernandez-Suarez G., Herrero R., Cavazza-Porro M., Dominguez R., Morgan D. (2013) Gastric cancer incidence and mortality is associated with altitude in the mountainous regions of Pacific Latin America Cancer Causes Control; 24(2):249-256.

65. Herrero R. (2013) HPV and Cervical Cancer ; .

66. Bedoya A.M., Jaramillo R., Baena A., Castano J., Olaya N., Zea A.H., Herrero R., Sanchez G.I. (2013) Location and Density of Immune Cells in Precursor Lesions and Cervical Cancer Cancer Microenviron; 6(1):69-77.

67. Safaeian M., Porras C., Pan Y., Kreimer A., Schiller J.T., Gonzalez P., Lowy D.R., Wacholder S., Schiffman M., Rodriguez A.C., Herrero R., Kemp T., Shelton G., Quint W., Van Doorn L.J., Hildesheim A., Pinto L.A. (2013) Durable antibody responses following one dose of the bivalent human papillomavirus l1 virus-like particle vaccine in the costa rica vaccine trial Cancer Prev Res. (Phila); 6(11):1242-1250.

68. Park J.Y., Forman D., Greenberg E.R., Herrero R. (2013) Helicobacter pylori Eradication in the Prevention of Gastric Cancer: Are More Trials Needed? Curr Oncol Rep; 15(6):517-525.

69. Nascimento C., De Vuyst H. (2013) Prevalence and type distribution of HPV in carcinoma and intraepithelial neoplasia of the vulva and vagina: a meta-analysis HPV Today; 12-13.

70. Safaeian M., Kemp T.J., Pan D.Y., Porras C., Rodriguez A.C., Schiffman M., Cortes B., Katki H., Wacholder S., Schiller J.T., Gonzalez P., Penrose K., Lowy D.R., Quint W., Van Doorn L.J., Herrero R., Hildesheim A., Pinto L.A. (2013) Cross-protective vaccine efficacy of the bivalent HPV vaccine against HPV31 is associated with humoral immune responses: results from the Costa Rica Vaccine Trial Hum Vaccin. Immunother; 9(7):1399-1406.

71. De Vuyst H., Chung M.H., Baussano I., Mugo N.R., Tenet V., van Kemenade F.J., Rana F.S., Sakr S.R., Meijer C.J., Snijders P.J., Franceschi S. (2013) Comparison of HPV DNA testing in cervical exfoliated cells and tissue biopsies among HIV-positive women in Kenya Int. J Cancer; 133(6):1441-1446.

72. Lang Kuhs K.A., Gonzalez P., Struijk L., Castro F., Hildesheim A., Van Doorn L.J., Rodriguez A.C., Schiffman M., Quint W., Lowy D.R., Porras C., DelVecchio C., Katki H.A., Jimenez S., Safaeian M., Schiller J., Solomon D., Wacholder S., Herrero R., Kreimer A.R. (2013) Prevalence of and risk factors for oral human papillomavirus among young women in Costa Rica J Infect. Dis; 208(10):1643-1652.

73. Morgan D.R., Torres J., Sexton R., Herrero R., Salazar-Martinez E., Greenberg E.R., Bravo L.E., Dominguez R.L., Ferreccio C., Lazcano-Ponce E.C., Meza-Montenegro M.M., Pena E.M., Pena R., Correa P., Martinez M.E., Chey W.D., Valdivieso M., Anderson G.L., Goodman G.E., Crowley J.J., Baker L.H. (2013) Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities JAMA; 309(6):578-586.

74. Herrero R., Quint W., Hildesheim A., Gonzalez P., Struijk L., Katki H.A., Porras C., Schiffman M., Rodriguez A.C., Solomon D., Jimenez S., Schiller J.T., Lowy D.R., Van Doorn L.J., Wacholder S., Kreimer A.R. (2013) Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica PLoS ONE; 8(7):e68329.

75. Lin S.W., Ghosh A., Porras C., Markt S.C., Rodriguez A.C., Schiffman M., Wacholder S., Kemp T.J., Pinto L.A., Gonzalez P., Wentzensen N., Esser M.T., Matys K., Meuree A., Quint W., Van Doorn L.J., Herrero R., Hildesheim A., Safaeian M. (2013) HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays PLoS ONE; 8(1):e53067.